Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
RSS icon

20 startups join MATTER

Twenty new healthcare startups have joined MATTER, the Chicago-based innovation center that launched in February. 

Thumbnail

FDA launches beta version of precisionFDA, next generation gene sequencing platform

The U.S. Food and Drug Administration has launched the beta version of precisionFDA, the collaborative platform for the exploration of next-generation gene sequencing announced in August.

KP Ventures invests $10M in telemedicine technology provider

Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, has made a $10 million strategic investment in Vidyo, a leader in high quality visual communications. 

Study finds physical activity increases with text support

A texting intervention with a group of patients at risk for heart disease led to significant increases in physical activity levels, according to a study published by the Journal of the American Heart Association.

Siemens joins Cleveland's Global Center for Health Innovation

Siemens Healthcare is the 20th tenant-partner of the Global Center for Health Innovation in Cleveland.  

NJIT's head of research to take on POC technology for NIH

Atam Dhawan, the New Jersey Institute of Technology's vice provost for research, will help lead a federal initiative to map out strategies for better integrating point-of-care technologies (POC) such as heart monitors, cancer-testing kits and rehabilitation devices into the healthcare delivery system.

Thumbnail

Consultant talks innovation center trend

Innovation is on the minds of everyone in healthcare, it seems, and with good reason.

PwC predicts top trends for 2016

Innovation, behavioral health, cybersecurity and consolidation are some of the trends that will be impacting healthcare in 2016, according to PricewaterhouseCoopers' (PwC’s) Health Research Institute.

Displaying 3033 - 3040 of 6920

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.